Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Lundström T, Agrawal R, Menon V, Wolski K, Nissen SE. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA. 2020;324:2268–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L. Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews [Internet]. 2020 [cited 2023 Mar 22];Available from: https://doi.org/10.1002/14651858.CD003177.pub5/full

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif J-C, Ballantyne CM. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11–22.

Article  CAS  PubMed  Google Scholar 

Manson JE, Bassuk SS, Buring JE, VITAL Research Group. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol. 2020;198:105522.

Manson JE, Cook NR, Lee I-M, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE, VITAL Research Group. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380:23–32.

Nie X, Wager S. Quasi-oracle estimation of heterogeneous treatment effects. Biometrika. 2021;108:299–319.

Article  Google Scholar 

Künzel SR, Sekhon JS, Bickel PJ, Yu B. Metalearners for estimating heterogeneous treatment effects using machine learning. Proc Natl Acad Sci. 2019;116:4156–65.

Article  PubMed  PubMed Central  Google Scholar 

Kennedy EH. Towards optimal doubly robust estimation of heterogeneous causal effects. Electron J Stat. 2023;17:3008–49.

Article  Google Scholar 

Wager S, Athey S. Estimation and inference of heterogeneous treatment effects using random forests. J Am Stat Assoc. 2018;113:1228–42.

Article  CAS  Google Scholar 

Zhao Y, Zeng D, Rush AJ, Kosorok MR. Estimating individualized treatment rules using outcome weighted learning. J Am Stat Assoc. 2012;107:1106–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imai K, Li ML. Experimental evaluation of individualized treatment rules. J Am Stat Assoc. 2021;1–15.

Buell KG, Spicer AB, Casey JD, Seitz KP, Qian ET, Graham Linck EJ, Self WH, Rice TW, Sinha P, Young PJ, Semler MW, Churpek MM. Individualized treatment effects of oxygen targets in mechanically ventilated critically Ill adults. JAMA [Internet]. 2024 [cited 2024 Mar 22]. Available from: https://doi.org/10.1001/jama.2024.2933

Wang G, Heagerty PJ, Dahabreh IJ. Using effect scores to characterize heterogeneity of treatment effects. JAMA [Internet]. 2024 [cited 2024 Mar 22]. Available from: https://doi.org/10.1001/jama.2024.3376

Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott P, King M, Omar RZ. How to develop a more accurate risk prediction model when there are few events. BMJ. 2015;351: h3868.

Article  PubMed  PubMed Central  Google Scholar 

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand J-P, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez -Sendon Jose-Luis, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. J Am College Cardiol. 2012;60:1581–98.

Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.

Manson JE, Cook NR, Lee I-M, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE, VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33–44.

Athey S, Imbens G. Recursive partitioning for heterogeneous causal effects. Proc Natl Acad Sci USA. 2016;113:7353–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chernozhukov V, Demirer M, Duflo E, Fern’andez-Val I. Generic machine learning inference on heterogenous treatment effects in randomized experiments [Internet]. arXiv.org; 2020 [cited 2022 Jan 17]. Available from: https://ideas.repec.org/p/arx/papers/1712.04802.html

Imai K, Li ML. Statistical inference for heterogeneous treatment effects discovered by generic machine learning in randomized experiments [Internet]. 2022 [cited 2023 Mar 23]. Available from: http://arxiv.org/abs/2203.14511

NHANES—National Health and Nutrition Examination Survey Homepage [Internet]. 2024 [cited 2024 Mar 14]. Available from: https://www.cdc.gov/nchs/nhanes/index.htm

Robertson SE, Steingrimsson JA, Dahabreh IJ. Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2023;38:123–33.

Article  PubMed  PubMed Central  Google Scholar 

Feuerriegel S, Frauen D, Melnychuk V, Schweisthal J, Hess K, Curth A, Bauer S, Kilbertus N, Kohane IS, van der Schaar M. Causal machine learning for predicting treatment outcomes. Nat Med. 2024;30:958–68.

Article  CAS  PubMed  Google Scholar 

Hanson S, Thorpe G, Winstanley L, Abdelhamid AS, Hooper L, PUFAH group. Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. Br J Cancer. 2020;122:1260–70.

Rose G. Sick individuals and sick populations.

Chou R, Cantor A, Dana T, Wagner J, Ahmed A, Fu R, Ferencik M. Statin use for the primary prevention of cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): agency for healthcare research and quality (US); 2022 [cited 2023 Jun 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK583661/

Chernozhukov V, Chetverikov D, Demirer M, Duflo E, Hansen C, Newey W, Robins J. Double/debiased machine learning for treatment and structural parameters. Economet J. 2018;21:C1–68.

Article  Google Scholar 

Willett W. Nutritional Epidemiology. OUP USA; 2013.

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial. Circulation. 2021;143:528–39.

Ridker PM, Rifai N, MacFadyen J, Glynn RJ, Jiao L, Steg PhG, Miller M, Brinton EA, Jacobson TA, Tardif J-C, Ballantyne CM, Mason RP, Bhatt DL. Effects of randomized treatment with icosapent ethyl and a mineral oil comparator on interleukin-1β, interleukin-6, C-reactive protein, oxidized low-density lipoprotein cholesterol, homocysteine, lipoprotein(a), and lipoprotein-associated phospholipase A2: a REDUCE-IT biomarker substudy. Circulation. 2022;146:372–9.

Article  CAS  PubMed  Google Scholar